Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
Holding BIVI?
Track your performance easily
BIVI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.07 - $58.20
Previous Close$2.9
Volume39.95K
Average Volume (3M)102.39K
Market Cap
$18.80M
Enterprise Value-$3.57M
Total Cash (Recent Filing)$30.35M
Total Debt (Recent Filing)$8.42M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
May 13, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.62
Shares Outstanding6,116,552
10 Day Avg. Volume45,143
30 Day Avg. Volume102,391
Standard Deviation0.42
R-Squared0.02
Alpha0.00657
Financial Highlights & Ratios
Price to Book (P/B)0.94
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.41
Forecast
1Y Price Target
$30.00Price Target Upside910.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
BioVie News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIVI FAQ
What was BioVie’s price range in the past 12 months?
BioVie lowest stock price was $2.07 and its highest was $58.20 in the past 12 months.
What is BioVie’s market cap?
Currently, no data Available
When is BioVie’s upcoming earnings report date?
BioVie’s upcoming earnings report date is May 13, 2024 which is 129 days ago.
How were BioVie’s earnings last quarter?
BioVie released its earnings results on Feb 14, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.055.
Is BioVie overvalued?
According to Wall Street analysts BioVie’s price is currently Undervalued.
Does BioVie pay dividends?
BioVie does not currently pay dividends.
What is BioVie’s EPS estimate?
BioVie’s EPS estimate is -$0.29.
How many shares outstanding does BioVie have?
BioVie has 6,330,860 shares outstanding.
What happened to BioVie’s price movement after its last earnings report?
BioVie reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went down -0.823%.
Which hedge fund is a major shareholder of BioVie?
Among the largest hedge funds holding BioVie’s share is Sheaff Brock Investment Advisors LLC. It holds BioVie’s shares valued at 21K.
---
BioVie Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.00 (910.10% Upside)
$30.00 (910.10% Upside)
Blogger Sentiment
Bullish
BIVI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.93%
12-Months-Change
Fundamentals
Return on Equity
-178.58%
Trailing 12-Months
Asset Growth
-29.68%
Trailing 12-Months
Company Description
BioVie
BioVie, Inc. is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA.
---
BIVI Stock 12 Month Forecast
Average Price Target
$30.00
▲(910.10% Upside)
Technical Analysis
Best Analysts Covering BIVI
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-30.30%
initiated a buy rating 3 months ago
Copying Ashok Kumar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -30.30% per trade.
---